05:13 PM EDT, 08/05/2024 (MT Newswires) -- Hims & Hers Health ( HIMS ) reported Q2 earnings late Monday of $0.06 per diluted share, swinging from a loss of $0.03 a year earlier.

Analysts polled by Capital IQ expected earnings of $0.05 per share.

Revenue in the quarter ended June 30 rose to $315.6 million from $207.9 million a year earlier.

Analysts surveyed by Capital IQ expected $302.4 million.

The company expects Q3 revenue of $375 million to $380 million. Analysts surveyed by Capital IQ expect $329.4 million.

The company raised full-year revenue guidance to $1.37 billion to $1.4 billion from $1.2 billion to $1.23 billion. Analysts surveyed by Capital IQ expect $1.26 billion.

Shares of the company fell 3.3% in after-hours trading.

Price: 17.26, Change: -0.58, Percent Change: -3.25